Egalet awarded new U.S. patent covering Guardian Technology

The USPTO awards U.S. Patent No. 9,642,809 to Egalet covering its abuse-deterrent Guardian Technology used to create immediate-, delayed- and/or extended-release tablets for precise drug delivery of one or two different active pharmaceutical ingredients. The patent will be in effect through June 4, 2028. CEO Bob Radie says, "The newly issued patent adds to [...]